1 completed, 1 withdrawn. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
| Phase 3 | 1 | Completed 1 |
Follow Xequel Bio, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of the Efficacy and Safety of Granexin® Gel to Improve Burn Wound Healing Granexin® gel (200 μM), Vehicle gel - Second Degree Burn, Thermal Burn | Phase 2 | Withdrawn | Xequel Bio, Inc. | 2022-08-01 | 2023-06-22 | |
| A Study of Granexin® Gel for the Reduction of Scar Formation in Surgical Wounds Following Bilateral Anchor Incision Breast Surgery Granexin® gel 100 μM, Granexin® gel 200 μM, Vehicle gel - Mammoplasty, Scarring | Phase 2 / Phase 3 | Completed | Xequel Bio, Inc. | 184 | 2020-07-01 | 2022-06-06 |
Cicatrix (1)
United States (1)